Skip to main content

Table 1 Preoperative patients' baseline characteristics

From: Evaluation of intra-operative trans-urethral endoscopic management of possible open transvesical prostatectomy complications

Characteristics

Group A

N = 25 standard

Group B

N = 25 endoscopic assisted

p value

Mean (SD, range)

Age (years)

52.0 (14.0, 49–71)

51.0 (14.2, 48–73)

0.803

BMI (kg/m2)

26.5 (4.3, 20–40.1)

27.2 (4.6, 21–41.2)

0.581

IPSS

20.3 (6.8, 11–33)

21.1 (7.1, 2–35)

0.686

Prostate size by TRUS (gm)

105.0 (17.4, 95–155)

107.0 (17.9, 88–170)

0.691

PVRU (ml)

95.5 (27.1, 52–127)

81.9 (26.8, 62–159)

0.081

Qmax. (ml/s)

8.8 (3.1, 2–11)

9.1 (4.1, 3–11)

0.771

PSA level (ng/ml

5.1 (2.1, 4.1–6.6)

5.3 (2.4, 4–7.3)

0.755

Hb level (g/dl)

13.2 (3.4, 10.5–15.1)

12.9 (3.2, 11.2–14.3)

0.749

Hct level (g/dl)

40.1 (9.4, 37.2–45.1)

39.7 (8.9, 35.6–44.8)

0.877

Serum creatinine (mg/ dl)

1.32 (0.2, 1.02–1.07)

1.25 (0.1, 0.9–1.42)

0.124

  1. p values are based on independent t test
  2. BMI, Body Mass Index; IPSS, International Prostatism Symptom Score; TRUS, transrectal ultrasonography; PVRU, post-void residual urine; Qmax, maximum flow rate; PSA, prostate-specific antigen; SD, standard deviation